Cambridge, MA, United States of America

Michael Badman

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.4

ph-index = 1


Location History:

  • Newton, MA (US) (2021)
  • Cambridge, MA (US) (2021 - 2022)

Company Filing History:


Years Active: 2021-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Michael Badman: Innovator in Liver and Gastrointestinal Disorders

Introduction

Michael Badman is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of medical research, particularly in the treatment of liver and gastrointestinal disorders. With a total of 4 patents to his name, Badman is recognized for his innovative approaches to healthcare.

Latest Patents

Among his latest patents, Badman has developed methods for treating liver disorders using FXR agonists. This invention provides methods for modulating the activity of farnesoid X receptors (FXRs) specifically for treating or preventing liver diseases. Additionally, he has patented methods for treating gastrointestinal disorders using FXR agonists, which also focus on modulating FXR activity to address liver and gastrointestinal diseases.

Career Highlights

Michael Badman is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to further his research and development efforts in the medical field, contributing to advancements in treatment methodologies.

Collaborations

Throughout his career, Badman has collaborated with notable colleagues, including Bryan Laffitte and Jin Ling Chen. These partnerships have enhanced his research capabilities and fostered innovation in his projects.

Conclusion

Michael Badman stands out as an influential inventor in the realm of medical research, particularly in the treatment of liver and gastrointestinal disorders. His patents and collaborations reflect his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…